In a filing, GeneDx Holdings Corp revealed its Chief Executive Officer Stueland Katherine unloaded Company’s shares for reported $0.47 million on Sep 09 ’25. In the deal valued at $128.06 per share,3,657 shares were sold. As a result of this transaction, Stueland Katherine now holds 6,329 shares worth roughly $0.77 million.
Then, Feeley Kevin sold 1,272 shares, generating $162,886 in total proceeds. Upon selling the shares at $128.05, the CHIEF FINANCIAL OFFICER now owns 5,286 shares.
Before that, Feeley Kevin sold 378 shares. GeneDx Holdings Corp shares valued at $47,556 were divested by the CHIEF FINANCIAL OFFICER at a price of $125.81 per share. As a result of the transaction, Feeley Kevin now holds 4,096 shares, worth roughly $0.5 million.
Piper Sandler initiated its GeneDx Holdings Corp [WGS] rating to an Overweight in a research note published on July 09, 2025; the price target was $110. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies also remained covering WGS and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Hold” rating. Wells Fargo started covering the stock on August 28, 2024. It rated WGS as “an Equal weight”.
Price Performance Review of WGS
On Tuesday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock fall -0.55% to $121.37. Over the last five days, the stock has lost -3.65%. GeneDx Holdings Corp shares have risen nearly 217.97% since the year began. Nevertheless, the stocks have risen 57.91% over the past one year.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-08-29, dropping by 6176.0 shares to a total of 3.63 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 3.64 million shares. There was a decline of -0.17%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 10, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.
